Companies that own Abzena PLC
Invesco Asset Management Ltd.
91,191,381
42.57%
36,020,102
0.02%
08/16/2018
Woodford Investment Management Ltd.
50,724,956
23.68%
18,882,456
0.07%
08/16/2018
Hargreave Hale Ltd.
21,727,500
10.14%
-1,727,000
0.05%
08/16/2018
Baillie Gifford & Co.
4,548,929
2.12%
28,777
0%
03/31/2017
Oddo BHF Asset Management SAS
2,510,723
1.17%
2,510,723
0.01%
08/16/2018
T. Rowe Price Associates, Inc.
2,143,095
1%
2,143,095
0%
08/16/2018
SVM Asset Management Ltd.
2,062,000
0.96%
512,000
0.08%
12/31/2017
BlackRock Investment Management (UK) Ltd.
1,925,554
0.9%
-875,946
0%
06/30/2018
Rathbone Investment Management Ltd.
1,424,000
0.67%
-130,000
0%
06/01/2018
Hargreaves Lansdown Stockbrokers Ltd.
876,000
0.41%
44,000
0%
06/01/2018
| Address |
Babraham Research Campus
Cambridge Cambridgeshire CB22 3AT
United Kingdom
|
|
Employees
|
- |
| Website |
http://abzena.com/ |
| Updated |
09/14/2018 |
| Abzena Plc engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It operates through the following segments: Biology, Chemistry, and Biomanufacturing. Its services include: antibody discovery and candidate screening; immunology and immunogenicity assessment; antibody and protein engineering to reduce immunogenicity; and custom synthesis of cytotoxic payloads, reagents, and other small molecules. |
